Alumis Inc. (ALMS) vs SpyGlass Pharma, Inc. Common Stock (SGP)
A side-by-side comparison of Alumis Inc. and SpyGlass Pharma, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALMS
Alumis Inc.
$6.93HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SGP
SpyGlass Pharma, Inc. Common Stock
$24.78HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALMS vs SGP
growth of $100 · dividends reinvested · last 1yALMS -73.9% (-73.9%/yr)SGP -3.1% (-3.1%/yr)SGP compounded faster over this window
ALMS SGP
ALMS vs SGP: by the numbers
- •ALMS is the larger company ($855M vs $828M market cap).
- •Both run net losses; SGP's is the smaller (0.00% vs -5933.45% net margin).
Metrics side by side
Valuation
| Metric | ALMS | SGP |
|---|---|---|
| P/S ratio | 115.62 | N/A |
| P/B ratio | 1.89 | 3.57 |
Profitability
| Metric | ALMS | SGP |
|---|---|---|
| Gross margin | 88.23% | 0.00% |
| Operating margin | -1776.32% | 0.00% |
| Net margin | -5933.45% | 0.00% |
| ROE | -97.08% | -24.12% |
| ROIC | -94.76% | -26.54% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.